Cargando…
Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications
BACKGROUND: The World Health Organization (WHO), like many other organisations around the world, has recognised the need to use more rigorous processes to ensure that health care recommendations are informed by the best available research evidence. This is the 11(th )of a series of 16 reviews that h...
Autor principal: | Edejer, Tessa Tan-Torres |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764011/ https://www.ncbi.nlm.nih.gov/pubmed/17147813 http://dx.doi.org/10.1186/1478-4505-4-23 |
Ejemplares similares
-
Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity
por: Oxman, Andrew D, et al.
Publicado: (2006) -
Cost-Effectiveness and Resource Allocation (CERA) – directions for the future
por: Baltussen, Rob, et al.
Publicado: (2009) -
Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update"
por: Bertram, Melanie Y., et al.
Publicado: (2021) -
Generalized cost-effectiveness analysis for national-level priority-setting in the health sector
por: Hutubessy, Raymond, et al.
Publicado: (2003) -
Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study
por: Stenberg, Karin, et al.
Publicado: (2019)